ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT00706914

Public ClinicalTrials.gov record NCT00706914. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 4:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter, 4-Week Pilot Study to Assess Symptoms in Stable, Moderate to Severe COPD Patients Taking Aclidinium Bromide 200 mcg Once Daily in Combination With Formoterol Fumarate Once or Twice Daily Versus Formoterol Fumarate Twice Daily

Study identification

NCT ID
NCT00706914
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
156 participants

Conditions and interventions

Interventions

  • Once-daily aclidinium/formoterol Drug
  • Once-daily formoterol fumarate Drug
  • Placebo to formoterol fumarate Drug
  • Twice-daily formoterol fumarate Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2008
Primary completion
Nov 10, 2008
Completion
Nov 10, 2008
Last update posted
May 14, 2017

2008

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
39
Facility City State ZIP Site status
Forest Investigative Site Tucson Arizona 85715
Forest Investigative Site Tucson Arizona 85741
Forest Investigative Site Fullerton California 92835
Forest Investigative Site Lakewood California 90712
Forest Investigative Site Rancho Mirage California 92270
Forest Investigative Site Redlands California 92373
Forest Investigative Site San Diego California 92120
Forest Investigative Site San Jose California 95124
Forest Investigative Site Stockton California 95207
Forest Investigative Site Wheat Ridge Colorado 80033
Forest Investigative Site Hartford Connecticut 06105
Forest Investigative Site New Britain Connecticut 06053
Forest Investigative Site Waterbury Connecticut 06708
Forest Investigative Site DeLand Florida 32720
Forest Investigative Site Panama City Florida 32405
Forest Investigative Site Tamarac Florida 33321
Forest Investigative Site Tampa Florida 33603
Forest Investigative Site Atlanta Georgia 30342
Forest Investigative Site Austell Georgia 30106
Forest Investigative Site Blue Ridge Georgia 30513
Forest Investigative Site Bowling Green Kentucky 42101
Forest Investigative Site Hazard Kentucky 41701
Forest Investigative Site North Dartmouth Massachusetts 02747
Forest Investigative Site Rochester Minnesota 55905
Forest Investigative Site Florissant Missouri 63033
Forest Investigative Site Saint Charles Missouri 63301
Forest Investigative Site St Louis Missouri 63110
Forest Investigative Site Albany New York 12205
Forest Investigative Site Charlotte North Carolina 28207
Forest Investigative Site Cincinnati Ohio 45242
Forest Investigative Site Columbus Ohio 43215
Forest Investigative Site Medford Oregon 97504
Forest Investigative Site Pittsburgh Pennsylvania 15213
Forest Investigative Site East Providence Rhode Island 02914
Forest Investigative Site Spartanburg South Carolina 29303
Forest Investigative Site Dallas Texas 75246
Forest Investigative Site McKinney Texas 75069
Forest Investigative Site Midvale Utah 84047
Forest Investigative Site Richmond Virginia 23225
Forest Investigative Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00706914, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2017 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00706914 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →